Search results
AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
The Independent via Yahoo News· 2 days agoThe application to withdraw the vaccine from the EU was...variant Covid-19 vaccines have since been...
AstraZeneca withdraws its vaccine to protect against COVID-19 worldwide
CBC via Yahoo News· 1 day agoAstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global...
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
RTT News· 2 days agoMeanwhile, AstraZeneca reportedly had admitted recently in court documents that the vaccine could cause side-effects such as blood clots and low blood platelet counts. The latest move follows ...
NanoViricides completes Phase 1 trial for respiratory viral infection candidate
Proactive Investors· 1 week agoIt has been found to be active against coronavirus infection, RSV infection, and smallpox and...
From flooding in Houston and Brazil to brutal heat in Asia, extreme weather seems nearly everywhere
WKBT La Crosse· 1 day agoVoters and politicians in the world's largest election in India are fainting in heat that hit as...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 1 week agoI Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1...
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Digital Journal· 2 days agoSHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral ...